Search research articles
Contact Us
Filters
Showing results (11-20 of 246) with videos related to
Page
of 25
Sort By:
The Journal of Clinical Investigation
|
November 1, 1996
A carboxy-terminal truncated insulin receptor substrate-1 dominant negative protein reverses the human hepatocellular carcinoma malignant phenotype
S Tanaka, J R Wands
Journal of Viral Hepatitis
|
January 1, 1994
The molecular pathogenesis of hepatocellular carcinoma
D Moradpour, J R Wands
Alcoholism, Clinical and Experimental Research
|
August 3, 2000
Ethanol inhibition: the humoral and cellular immune response to hepatitis C virus NS5 protein after genetic immunization
J Encke, J R Wands
Hepatology (Baltimore, Md.)
|
September 26, 1997
Hepatitis C virus: epidemiology and transmission
T Heintges, J R Wands
Gastroenterology
|
February 1, 1981
High affinity monoclonal antibodies to hepatitis B surface antigen (HBsAg) produced by somatic cell hybrids
J R Wands, V R Zurawski
Alcoholism, Clinical and Experimental Research
|
August 1, 1988
Ethanol-induced inhibition of liver cell function: I. Effect of ethanol on hormone stimulated hepatocyte DNA synthesis and the role of ethanol metabolism
E A Carter, J R Wands
Seminars in Liver Disease
|
February 1, 1984
Monoclonal antibodies as diagnostic probes in the etiology of hepatitis
E Ben-Porath, J R Wands
Springer Seminars in Immunopathology
|
December 1, 1980
Immunologic effector mechanisms in hepatitis B-negative chronic active hepatitis
R J Klingenstein, J R Wands
Antisense & Nucleic Acid Drug Development
|
August 6, 1999
Specific inhibition of hepatitis B virus replication by sense RNA
J zu Putlitz, J R Wands
Journal of Gastroenterology and Hepatology
|
November 1, 2001
Ribozymes and hepatitis B virus
H C Spangenberg, J R Wands
Page
of 25
Search research articles
Search
Showing results (11-20 of 246) with videos related to
Sort By:
Page
of 25
The Journal of Clinical Investigation
|
November 1, 1996
A carboxy-terminal truncated insulin receptor substrate-1 dominant negative protein reverses the human hepatocellular carcinoma malignant phenotype
S Tanaka, J R Wands
Journal of Viral Hepatitis
|
January 1, 1994
The molecular pathogenesis of hepatocellular carcinoma
D Moradpour, J R Wands
Alcoholism, Clinical and Experimental Research
|
August 3, 2000
Ethanol inhibition: the humoral and cellular immune response to hepatitis C virus NS5 protein after genetic immunization
J Encke, J R Wands
Hepatology (Baltimore, Md.)
|
September 26, 1997
Hepatitis C virus: epidemiology and transmission
T Heintges, J R Wands
Gastroenterology
|
February 1, 1981
High affinity monoclonal antibodies to hepatitis B surface antigen (HBsAg) produced by somatic cell hybrids
J R Wands, V R Zurawski
Alcoholism, Clinical and Experimental Research
|
August 1, 1988
Ethanol-induced inhibition of liver cell function: I. Effect of ethanol on hormone stimulated hepatocyte DNA synthesis and the role of ethanol metabolism
E A Carter, J R Wands
Seminars in Liver Disease
|
February 1, 1984
Monoclonal antibodies as diagnostic probes in the etiology of hepatitis
E Ben-Porath, J R Wands
Springer Seminars in Immunopathology
|
December 1, 1980
Immunologic effector mechanisms in hepatitis B-negative chronic active hepatitis
R J Klingenstein, J R Wands
Antisense & Nucleic Acid Drug Development
|
August 6, 1999
Specific inhibition of hepatitis B virus replication by sense RNA
J zu Putlitz, J R Wands
Journal of Gastroenterology and Hepatology
|
November 1, 2001
Ribozymes and hepatitis B virus
H C Spangenberg, J R Wands
Page
of 25